NASDAQ:BHTGBioHiTech Global Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioHiTech Global Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.09 -0.03 (-2.68 %) (As of 05/28/2020 04:00 PM ET) Add Compare Share Today's Range$1.09Now: $1.09▼$1.1850-Day Range$1.13MA: $1.24▼$1.3552-Week Range$1.01Now: $1.09▼$2.50Volume29,105 shsAverage Volume23,822 shsMarket Capitalization$19.01 millionP/E RatioN/ADividend YieldN/ABeta1.85 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. It has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingBioHiTech Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.75, BioHiTech Global has a potential upside of 244.0% from its current price of $1.09.Amount of Analyst CoverageBioHiTech Global has only been the subject of 1 research reports in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesBioHiTech Global has received 123 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioHiTech Global has received 129 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioHiTech Global has received 51.19% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioHiTech Global and other stocks. Vote “Outperform” if you believe BHTG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BHTG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBioHiTech Global does not currently pay a dividend.Dividend GrowthBioHiTech Global does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioHiTech Global insiders have not sold or bought any company stock.Percentage Held by Insiders41.90% of the stock of BioHiTech Global is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 6.68% of the stock of BioHiTech Global is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of BioHiTech Global is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioHiTech Global is -1.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioHiTech Global has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.38 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Educational services Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:BHTG Previous Symbol CUSIPN/A CIK1590383 Webwww.biohitech.com Phone845-262-1081Debt Debt-to-Equity Ratio7.41 Current Ratio0.74 Quick Ratio0.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$4.22 million Price / Sales4.50 Cash FlowN/A Price / Cash FlowN/A Book Value$0.37 per share Price / Book2.95Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-14,670,000.00 Net Margins-193.11% Return on Equity-176.04% Return on Assets-13.50%Miscellaneous EmployeesN/A Outstanding Shares17,437,000Market Cap$19.01 million Next Earnings Date6/3/2020 (Estimated) OptionableNot Optionable NASDAQ:BHTG Rates by TradingView Receive BHTG News and Ratings via Email Sign-up to receive the latest news and ratings for BHTG and its competitors with MarketBeat's FREE daily newsletter. BioHiTech Global (NASDAQ:BHTG) Frequently Asked Questions How has BioHiTech Global's stock been impacted by COVID-19 (Coronavirus)? BioHiTech Global's stock was trading at $1.71 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BHTG stock has decreased by 36.3% and is now trading at $1.09. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of BioHiTech Global? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for BioHiTech Global. When is BioHiTech Global's next earnings date? BioHiTech Global is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for BioHiTech Global. How were BioHiTech Global's earnings last quarter? BioHiTech Global Inc (NASDAQ:BHTG) announced its quarterly earnings results on Tuesday, May, 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.14). The company had revenue of $1.01 million for the quarter. BioHiTech Global had a negative return on equity of 176.04% and a negative net margin of 193.11%. View BioHiTech Global's earnings history. What price target have analysts set for BHTG? 2 analysts have issued 12-month target prices for BioHiTech Global's stock. Their forecasts range from $2.50 to $5.00. On average, they anticipate BioHiTech Global's share price to reach $3.75 in the next year. This suggests a possible upside of 244.0% from the stock's current price. View analysts' price targets for BioHiTech Global. Has BioHiTech Global been receiving favorable news coverage? News headlines about BHTG stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioHiTech Global earned a news sentiment score of 1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutBioHiTech Global. Are investors shorting BioHiTech Global? BioHiTech Global saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 32,000 shares, an increase of 6.0% from the April 30th total of 30,200 shares. Based on an average daily trading volume, of 21,200 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.3% of the company's stock are sold short. View BioHiTech Global's Current Options Chain. Who are some of BioHiTech Global's key competitors? Some companies that are related to BioHiTech Global include RYB Education (RYB), Four Seasons Edu (Cayman) (FEDU), Zhongchao (ZCMD), CIBT Education Group (MBAIF), ATA (ATAI), National American University Holdngs (NAUH), Wah Fu Education Group (WAFU), Scientific Learning (SCIL), ChineseInvestors.com (CIIX), PCS Edventures! (PCSV), Legacy Education Alliance (LEAI), Creative Learning (CLCN), Blue Calypso (BCYP), Eos International (EOSI) and Learning Tree International (LTRE). View all competitors. What other stocks do shareholders of BioHiTech Global own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioHiTech Global investors own include Opko Health (OPK), Bellicum Pharmaceuticals (BLCM), NVIDIA (NVDA), TransEnterix (TRXC), DISH Network (DISH), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Athersys (ATHX), Actinium Pharmaceuticals (ATNM) and Aytu Bioscience (AYTU). What is BioHiTech Global's stock symbol? BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG." Who are BioHiTech Global's major shareholders? BioHiTech Global's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (0.41%) and Victory Capital Management Inc. (0.41%). Company insiders that own BioHiTech Global stock include Frank E Celli, James D Chambers and Robert A Joyce. View institutional ownership trends for BioHiTech Global. Which major investors are selling BioHiTech Global stock? BHTG stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., and Victory Capital Management Inc.. View insider buying and selling activity for BioHiTech Global. How do I buy shares of BioHiTech Global? Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BioHiTech Global's stock price today? One share of BHTG stock can currently be purchased for approximately $1.09. How big of a company is BioHiTech Global? BioHiTech Global has a market capitalization of $19.01 million and generates $4.22 million in revenue each year. What is BioHiTech Global's official website? The official website for BioHiTech Global is www.biohitech.com. How can I contact BioHiTech Global? BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at 845-262-1081 or via email at [email protected] This page was last updated on 5/28/2020 by MarketBeat.com Staff
